Double Knockdown of PHD1 and Keap1 Attenuated Hypoxia-Induced Injuries in Hepatocytes

Jing Liu1, Yiping Li1, Lei Liu1

  • 1Department of Pathology and Pathophysiology, School of Medicine, Southeast UniversityNanjing, China.

Insights

Targeting prolyl hydroxylase 1 (PHD1) and kelch-like ECH associated protein 1 (Keap1) with shRNA reduces liver fibrosis. This approach mitigates hypoxia and oxidative stress in hepatocytes, inhibiting hepatic stellate cell activation for potential liver fibrosis treatment.

Area of Science:

  • Hepatology
  • Molecular Biology
  • Cell Biology

Background:

  • Liver fibrosis is exacerbated by hypoxia and oxidative stress.
  • Prolyl hydroxylase 1 (PHD1) acts as an intracellular oxygen sensor, while kelch-like ECH associated protein 1 (Keap1) functions as an oxidative stress sensor.
  • Investigating the roles of PHD1 and Keap1 in hypoxic hepatocytes is crucial for understanding liver fibrosis pathogenesis.

Purpose of the Study:

  • To investigate the functional roles of PHD1 and Keap1 in hypoxic hepatocytes.
  • To evaluate the therapeutic potential of targeting PHD1 and Keap1 in liver fibrosis.
  • To explore the effects of PHD1 and Keap1 knockdown on hepatocyte injury and hepatic stellate cell activation.

Main Methods:

  • Established a carbon tetrachloride (CCl4)-induced liver fibrosis model in rats.
  • Utilized small hairpin RNA (shRNA) to co-knockdown PHD1 and Keap1 in AML12 hepatocytes in vitro.
  • Assessed hypoxia markers (HIF-1α, HIF-2α), oxidative stress markers (Keap1, Nrf2), apoptosis, cell viability, and pro-fibrogenic molecule expression.
  • Evaluated the impact of conditioned medium from treated hepatocytes on rat hepatic stellate cells (HSC-T6).

Main Results:

  • Hypoxia and oxidative stress markers were upregulated in fibrotic livers.
  • Double-knockdown of PHD1 and Keap1 in AML12 cells reduced hypoxia-induced oxidative stress and apoptosis, enhancing cell viability.
  • Knockdown also downregulated pro-fibrogenic molecules in hepatocytes and inhibited activation of HSC-T6 cells cultured in conditioned medium.

Conclusions:

  • Simultaneous knockdown of PHD1 and Keap1 attenuates hypoxia and oxidative stress-induced hepatocyte injury.
  • This dual knockdown inhibits hepatic stellate cell activation, suggesting a novel therapeutic strategy for liver fibrosis.
  • Targeting PHD1 and Keap1 offers potential for liver fibrosis prophylaxis and treatment.